(Q28485386)
Statements
A systemically-administered small molecule antagonist of CCR9 acts as a tissue-selective inhibitor of lymphocyte trafficking (English)
0 references
2012
0 references
7
0 references
11
0 references
e50498
0 references
29 November 2012
1 reference